January 5, 2017 / 1:55 PM / 8 months ago

BRIEF-Gemphire Therapeutics provides clinical update

Jan 5 (Reuters) - Gemphire Therapeutics Inc :

* Gemphire Therapeutics provides clinical update

* Gemphire Therapeutics provides clinical update

* Gemphire Therapeutics inc - interim data from cobalt-1 trial for homozygous familial hypercholesterolemia (hofh) patients expected week of january 30, 2017

* Gemphire Therapeutics inc - indigo-1 trial commenced for severe hypertriglyceridemia (shtg) patients

* Gemphire now expects to complete enrollment in january and release top line data from royal-1 trial in q3 of 2017

* Gemphire Therapeutics inc - royal-1 clinical trial data expected in q3 of 2017

* Gemphire Therapeutics Inc- company expects to report top-line results from indigo-1 in q4 of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below